The Irish Association of Coloproctology, Limerick, Ireland.
Ann Surg Oncol. 2013 Oct;20(11):3414-21. doi: 10.1245/s10434-013-3131-2. Epub 2013 Aug 2.
Following a national audit of rectal cancer management in 2007, a national centralization program in the Republic of Ireland was initiated. In 2010, a prospective evaluation of rectal cancer treatment and early outcomes was conducted.
A total of 29 colorectal surgeons in 14 centers prospectively collated data on all patients with rectal cancer who underwent curative surgery in 2010.
Data were available on 447 patients who underwent proctectomy with curative intent for rectal cancer in 2010; 23.7 % of patients underwent abdominoperineal excision. The median number of lymph nodes identified was 12. The 30-day mortality rate was 1.1 %. Compared with 2007, there was a reduction in positive circumferential margin rate (15.8 vs 4.5 %, P < 0.001), clinical anastomotic leak rate (10.8 vs 4.3 %, P = 0.002), and postoperative radiotherapy use (17.8 vs 4.0 %, P < 0.001). Also, 53.9 % received preoperative radiotherapy in 2010. Four centers gave statistically more patients (high-administration), and four centers gave fewer patients (low-administration) preoperative radiotherapy for T2/T3 tumors (P < 0.05). On multivariate analysis, being treated in a "high-administration center" increased the likelihood (likelihood ratio [LR], 2.9; 95 % CI 1.7-4.8; P < 0.001) while attending a "low-administration center" (LR, 0.3; 95 % CI 0.2-0.5; P < 0.001) reduced the likelihood of receiving preoperative radiotherapy for a T2/T3 rectal cancer.
Patients undergoing rectal cancer surgery in hospitals following a national centralization initiative received high-quality surgery. Significant heterogeneity exists in radiotherapy administration, and evidence-based guidelines should be developed and implemented.
2007 年对直肠癌管理进行全国性审计后,爱尔兰共和国启动了全国集中化计划。2010 年,对直肠癌治疗和早期结果进行了前瞻性评估。
2010 年,14 个中心的 29 名结肠直肠外科医生前瞻性地收集了所有接受根治性手术的直肠癌患者的数据。
2010 年,447 名接受根治性直肠前切除术的患者的数据可用;23.7%的患者行腹会阴切除术。中位淋巴结检出数为 12 枚。30 天死亡率为 1.1%。与 2007 年相比,阳性环周切缘率(15.8%比 4.5%,P<0.001)、临床吻合口漏率(10.8%比 4.3%,P=0.002)和术后放疗使用率(17.8%比 4.0%,P<0.001)均降低。此外,2010 年 53.9%的患者接受术前放疗。四个中心给予更多患者(高剂量组)和四个中心给予更少患者(低剂量组)术前放疗(P<0.05)。多变量分析显示,在“高剂量组”中治疗增加了接受术前放疗的可能性(比值比 [LR],2.9;95%置信区间 1.7-4.8;P<0.001),而在“低剂量组”中治疗(LR,0.3;95%置信区间 0.2-0.5;P<0.001)降低了接受 T2/T3 直肠癌术前放疗的可能性。
在全国集中化倡议之后,在医院接受直肠癌手术的患者接受了高质量的手术。放疗管理存在显著的异质性,应制定和实施循证指南。